• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UCK2 上调可能作为肝细胞癌不良预后的一个指标。

UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.

机构信息

Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, Hubei, China.

出版信息

IUBMB Life. 2019 Jan;71(1):105-112. doi: 10.1002/iub.1941. Epub 2018 Oct 10.

DOI:10.1002/iub.1941
PMID:30304569
Abstract

Uridine-cytidine kinases (encoded by UCK1, UCKL1, and UCK2) catalyze the phosphorylation of uridine and cytidine to uridine monophosphate (UMP) and cytidine monophosphate (CMP). In this study, using data from the Cancer Genome Atlas (TCGA), we analyzed the expression profile of uridine-cytidine kinase genes in hepatocellular carcinoma (HCC), their prognostic value, and the epigenetic alterations associated with their dysregulation. Results showed that UCKL1 and UCK2, but not UCK1 were significantly upregulated in HCC tissues than in adjacent normal tissues. Only UCK2 was significantly upregulated in the deceased group and the recurrence group, compared to the control groups. Multivariate analysis confirmed that increased UCK2 expression was an independent prognostic indicator of shorter overall survival (OS) (HR: 1.760, 95% CI: 1.398-2.216, P < 0.001) and recurrence-free survival (RFS) (HR: 1.543, 95% CI: 1.232-1.933, P < 0.001). Two CpG sites (cg09277749 and cg21143899) were significantly hypomethylated in HCC tissues than in adjacent normal tissues and were negatively correlated with UCK2 expression. However, survival analysis showed that only high methylation of cg0927774 was associated with better OS and RFS of HCC patients. Based on the findings above, we infer that UCK2 upregulation might be a valuable prognostic marker in HCC. The methylation of status cg0927774 might play a critical role in its expression. © 2018 IUBMB Life, 71(1):105-112, 2019.

摘要

尿苷-胞苷激酶(由 UCK1、UCKL1 和 UCK2 编码)催化尿苷和胞苷磷酸化为尿苷单磷酸(UMP)和胞苷单磷酸(CMP)。在这项研究中,我们使用癌症基因组图谱(TCGA)的数据,分析了尿苷-胞苷激酶基因在肝细胞癌(HCC)中的表达谱、它们的预后价值以及与它们失调相关的表观遗传改变。结果表明,与相邻正常组织相比,HCC 组织中 UCKL1 和 UCK2,但不是 UCK1,显著上调。与对照组相比,只有 UCK2 在死亡组和复发组中显著上调。多变量分析证实,增加的 UCK2 表达是总生存期(OS)(HR:1.760,95%CI:1.398-2.216,P < 0.001)和无复发生存期(RFS)(HR:1.543,95%CI:1.232-1.933,P < 0.001)较短的独立预后指标。与相邻正常组织相比,HCC 组织中的两个 CpG 位点(cg09277749 和 cg21143899)显著低甲基化,并且与 UCK2 表达呈负相关。然而,生存分析表明,只有 cg0927774 的高甲基化与 HCC 患者的更好的 OS 和 RFS 相关。基于上述发现,我们推断 UCK2 的上调可能是 HCC 的有价值的预后标志物。cg0927774 的甲基化状态可能在其表达中起关键作用。© 2018 IUBMB Life,71(1):105-112,2019。

相似文献

1
UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.UCK2 上调可能作为肝细胞癌不良预后的一个指标。
IUBMB Life. 2019 Jan;71(1):105-112. doi: 10.1002/iub.1941. Epub 2018 Oct 10.
2
Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.尿苷-胞苷激酶 2 的上调预示着肝细胞癌的预后不良,并且与癌症的侵袭性有关。
Mol Carcinog. 2019 Apr;58(4):603-615. doi: 10.1002/mc.22954. Epub 2019 Jan 22.
3
The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastoma.尿苷 - 胞苷激酶在神经母细胞瘤嘧啶代谢及细胞毒性核苷类似物激活中的关键作用。
Biochim Biophys Acta. 2016 Sep;1862(9):1504-12. doi: 10.1016/j.bbadis.2016.05.012. Epub 2016 May 27.
4
Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines.神经母细胞瘤细胞系中两种尿苷 - 胞苷激酶同工型的纯化、活性及表达水平
Nucleosides Nucleotides Nucleic Acids. 2016 Dec;35(10-12):613-618. doi: 10.1080/15257770.2015.1124998.
5
Upregulated mH2A1 serves as an unfavorable prognostic indicator and promotes the progress of hepatocellular carcinoma (HCC).上调的 mH2A1 可作为不利的预后指标,并促进肝细胞癌(HCC)的进展。
Life Sci. 2020 Dec 15;263:118576. doi: 10.1016/j.lfs.2020.118576. Epub 2020 Oct 12.
6
Targeting uridine-cytidine kinase 2 induced cell cycle arrest through dual mechanism and could improve the immune response of hepatocellular carcinoma.靶向尿苷-胞苷激酶 2 通过双重机制诱导细胞周期停滞,并能提高肝癌的免疫反应。
Cell Mol Biol Lett. 2022 Nov 26;27(1):105. doi: 10.1186/s11658-022-00403-y.
7
Uridine-cytidine kinase 2 (UCK2): A potential diagnostic and prognostic biomarker for lung cancer.尿苷-胞苷激酶 2 (UCK2):肺癌潜在的诊断和预后生物标志物。
Cancer Sci. 2019 Sep;110(9):2734-2747. doi: 10.1111/cas.14125. Epub 2019 Aug 23.
8
regulated by miR-139-3p regulates the progression of hepatocellular carcinoma cells.受miR-139-3p调控影响肝癌细胞的进展。
Future Oncol. 2022 Mar;18(8):979-990. doi: 10.2217/fon-2021-0271. Epub 2022 Feb 9.
9
Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma.基于 snoRNA 编码的长链非编码 RNA 的生物信息学分析在肝细胞癌中的预后价值。
Biofactors. 2019 Mar;45(2):244-252. doi: 10.1002/biof.1478. Epub 2018 Dec 8.
10
Phosphorylation of uridine and cytidine by uridine-cytidine kinase.尿苷-胞苷激酶催化尿苷和胞苷的磷酸化反应。
J Biotechnol. 2014 Oct 20;188:81-7. doi: 10.1016/j.jbiotec.2014.08.018. Epub 2014 Aug 24.

引用本文的文献

1
Identification of epithelial-mesenchymal transition prognostic signature associated with prognosis, tumor microenvironment, and therapeutic effect in prostate cancer.鉴定与前列腺癌预后、肿瘤微环境及治疗效果相关的上皮-间质转化预后特征
Front Genet. 2025 Aug 11;16:1539745. doi: 10.3389/fgene.2025.1539745. eCollection 2025.
2
PET imaging of hepatocellular carcinoma with [I]IV-14.使用[I]IV-14对肝细胞癌进行正电子发射断层显像(PET)成像。
EJNMMI Res. 2025 Apr 7;15(1):35. doi: 10.1186/s13550-025-01227-5.
3
Uridine-cytidine kinase 2 is correlated with immune, DNA damage repair and promotion of cancer stemness in pan-cancer.
尿苷-胞苷激酶2与泛癌中的免疫、DNA损伤修复及癌症干性促进相关。
Front Oncol. 2025 Jan 27;15:1503300. doi: 10.3389/fonc.2025.1503300. eCollection 2025.
4
CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4-TGFα-EGFR signaling.环状 UCK2(2,3) 通过激活 CNIH4-TGFα-EGFR 信号通路促进癌症进展并增强乐伐替尼与 EGFR 抑制剂的协同细胞毒性。
Cell Mol Biol Lett. 2025 Jan 30;30(1):15. doi: 10.1186/s11658-025-00690-1.
5
mTORC1 regulates the pyrimidine salvage pathway by controlling UCK2 turnover via the CTLH-WDR26 E3 ligase.mTORC1通过CTLH-WDR26 E3连接酶控制UCK2的周转来调节嘧啶补救途径。
Cell Rep. 2025 Jan 28;44(1):115179. doi: 10.1016/j.celrep.2024.115179. Epub 2025 Jan 13.
6
UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis.UCK2通过PI3K/AKT/mTOR/自噬轴促进肝内胆管癌进展并使顺铂治疗脱敏。
Cell Death Discov. 2024 Aug 23;10(1):375. doi: 10.1038/s41420-024-02140-x.
7
Comprehensive analysis of DNA methylation gene expression profiles in GEO dataset reveals biomarkers related to malignant transformation of sinonasal inverted papilloma.对基因表达综合数据库(GEO)数据集中DNA甲基化基因表达谱的综合分析揭示了与鼻窦内翻性乳头状瘤恶变相关的生物标志物。
Discov Oncol. 2024 Mar 1;15(1):53. doi: 10.1007/s12672-024-00903-7.
8
CircUCK2 promotes hepatocellular carcinoma development by upregulating UCK2 in a mir-149-5p-dependent manner.环状UCK2通过以mir-149-5p依赖的方式上调UCK2来促进肝细胞癌的发展。
Discov Oncol. 2024 Jan 20;15(1):14. doi: 10.1007/s12672-024-00863-y.
9
Uridine-cytidine kinase 2 potentiates the mutagenic influence of the antiviral β-d-N4-hydroxycytidine.尿苷-胞苷激酶 2增强了抗病毒β-d-N4-羟基胞苷的诱变影响。
Nucleic Acids Res. 2023 Dec 11;51(22):12031-12042. doi: 10.1093/nar/gkad1002.
10
Development and validation of robust metabolism-related gene signature in the prognostic prediction of hepatocellular carcinoma.建立并验证与代谢相关的基因标志物,用于预测肝细胞癌的预后。
J Cell Mol Med. 2023 Apr;27(7):1006-1020. doi: 10.1111/jcmm.17718. Epub 2023 Mar 15.